“i didn’t know if it was the humidity or the barometric pressure, but i was in agony,” she says. “it feels like someone’s driven a stake into my legs. but it’s not constant, it doesn’t affect my work.”
sirhan says that because more routine blood tests are performed, the disease is being detected early.
“there was a study at the american society of hematology conference last year that showed that many of these mutations happen very early in life but we don’t know the cause,” she says.
research in this field has ‘exploded’
even though she’s mostly asymptomatic, pratt was prescribed ruxolitinib, a jak2 inhibitor that slows the production of platelets so her bones are not as fibrotic. her spleen is also regularly monitored to ensure it doesn’t get bigger, a sign that the cancer is progressing.
“since the jak 2 mutation has been identified, the research in this field has exploded,” says sirhan, noting that there are ongoing
clinical trials
for newer treatments. “the jak inhibitors made a huge difference for patients with symptoms and disease control, taking it from a rare disease with no treatments that made much of a difference, to lots of research to improve patient outcomes.”
sirhan says stem cell transplants may offer a cure, but they come with their own set of risks and complications so only a minority of patients are referred — usually those with a higher risk of disease, who are younger and in good health, and who have a suitable donor.
alternative treatments and lifestyle choices
in addition to the conventional treatment, pratt is also trying supplements, particularly a type of mushroom called turkey tail (
coriolus versicolor
) — her brother manages a vitamin and supplement store with many clients with cancer who use it to slow tumour growth and boost their immune system.